je.st
news
Pfizer acquires Swiss vaccine developer
2015-01-05 19:27:20| Biotech - Topix.net
As part of an ongoing effort to expand its vaccine business, Pfizer Inc. announced Monday that it has acquired a controlling interest in Redvax GmbH. The deal gives Pfizer access to Redvax's human cytomegalovirus vaccine candidate in preclinical testing, along with the company's intellectual property and a technology platform related to a second, undisclosed vaccine program.
Tags: developer
swiss
vaccine
acquires
Category:Biotechnology and Pharmaceuticals